Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
9926:HKG
Akeso Inc
HK$136.20
-0.15%
(-0.20) 1D
Apr 29, 4:08:36 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9926...
Open
HK$137.40
High
HK$138.40
Low
HK$135.20
Mkt. cap
125.46B
Avg. vol.
9.28M
Volume
4.18M
52-wk high
HK$179.00
52-wk low
HK$73.10
EPS
-HK$1.41
No. of employees
4K
News stories
From sources across the web
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong. It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees3.76K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
705.77M
705.77M
822.37M
822.37M
Cost of goods sold
153.29M
153.29M
172.86M
172.86M
Cost of revenue
153.29M
153.29M
172.86M
172.86M
Research and development expenses
365.62M
365.62M
421.91M
421.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
401.95M
401.95M
464.36M
464.36M
Operating expense
797.32M
797.32M
938.87M
938.87M
Total operating expenses
950.61M
950.61M
1.11B
1.11B
Operating income
-244.84M
-244.84M
-289.36M
-289.36M
Other non operating income
9.48M
9.48M
32.60M
32.60M
EBT including unusual items
-293.95M
-293.95M
-276.45M
-276.45M
EBT excluding unusual items
-297.71M
-297.71M
-272.68M
-272.68M
Income tax expense
192.50K
192.50K
-192.50K
-192.50K
Effective tax rate
-0.07%
-0.07%
0.07%
0.07%
Other operating expenses
29.74M
29.74M
52.60M
52.60M
Net income
-285.04M
-285.04M
-271.47M
-271.47M
Net profit margin
-40.39%
-40.39%
-33.01%
-33.01%
Earnings per share
-
-
-
-
Interest and investment income
65.18M
65.18M
84.42M
84.42M
Interest expense
-31.68M
-31.68M
-33.81M
-33.81M
Net interest expenses
33.50M
33.50M
50.61M
50.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-188.45M
-188.45M
-214.84M
-214.84M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more